SUCOSTRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sucostrin, and when can generic versions of Sucostrin launch?
Sucostrin is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in SUCOSTRIN is succinylcholine chloride. There are six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sucostrin
A generic version of SUCOSTRIN was approved as succinylcholine chloride by ZYDUS PHARMS on May 4th, 2018.
Summary for SUCOSTRIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Patent Applications: | 2,856 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SUCOSTRIN at DailyMed |
US Patents and Regulatory Information for SUCOSTRIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | SUCOSTRIN | succinylcholine chloride | INJECTABLE;INJECTION | 008847-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apothecon | SUCOSTRIN | succinylcholine chloride | INJECTABLE;INJECTION | 008847-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |